acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or r/r mcl
Published 1 year ago • 301 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:27
acalabrutinib in combination with umbralisib and ublituximab in previously untreated mcl
-
5:12
phase ii trial of acalabrutinib, lenalidomide and rituximab in patients with mcl
-
1:14
rationale for combining acalabrutinib with bendamustine and rituximab in mcl
-
1:12
traverse: acalabrutinib venetoclax and rituximab for treatment-naïve mcl
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
37:59
blinatumomab
-
4:20
stories of transformation - marianne
-
3:35
a trial investigating the addition of blinatumomab to consolidation chemotherapy in ph- all
-
1:03:15
blooducation baristas - platelets and paradigms with neil blumberg, md
-
1:51
safety and efficacy findings for acalabrutinib plus bendamustine and rituximab in mcl
-
3:35
trial of ibrutinib with bendamustine and rituximab in cll: results and study design
-
1:06
dr. phillips on the safety of acalabrutinib plus bendamustine/rituximab in mcl
-
2:52
updated analysis of phase iii trial of idelalisib combined with bendamustine and rituximab in cll
-
1:07
dr. wang on addition of acalabrutinib to bendamustine/rituximab in mcl
-
4:53
elevate tn: comparing acalabrutinib monotherapy or in combination with obinutuzumab in treatment...
-
3:06
durable responses to ibrutinib and venetoclax in r/r mcl: 3-year aim update
-
2:29
real-world comparison of ttnt with ibrutinib or acalabrutinib in cll
-
1:30
oasis trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed mcl
-
1:11
ibrutinib combined with tgr-1202 in cll and mantle cell lymphoma (mcl): preliminary results
-
5:29
helios trial: ibrutinib combined with br for previously treated cll/sll
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics
-
1:36
understanding red cell biology and how it relates to hemoglobinopathies